You are here

  • Home
  • Archive
  • Volume 7, Issue 10
  • Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design

Article info

Article menu

Download PDFPDF

XML
Public health
Research
Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design

Authors

  • Jesus Maria Aranaz Andrés Department of Preventive Medicine and Public Health, Hospital Universitario Ramón y Cajal, Madrid, Spain Center of Biomedical Network Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain Ramóny Cajal Biomedical Research Institute (IRYCIS), Madrid, Spain La Rioja International University (UNIR), Logroño, Spain PubMed articlesGoogle scholar articles
  • Ramon Limón Ramírez Department of Preventive Medicine and Quality of Healthcare, Hospital de la Plana, Castellón, Spain PubMed articlesGoogle scholar articles
  • Carlos Aibar Remón Department of Preventive Medicine and Public Health, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain Aragón Healthcare Research Institute (IIS), Zaragoza, Spain PubMed articlesGoogle scholar articles
  • Maria Teresa Gea-Velázquez de Castro Department of Preventive Medicine and Quality of Healthcare, Hospital Universitari Sant Joan d’Alacant, Sant Joan d’Alacant, Spain Department of Public Health, Science, History and Gynaecology, Miguel Hernández University, Sant Joan d’Alacant, Spain PubMed articlesGoogle scholar articles
  • Francisco Bolúmar Center of Biomedical Network Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain Unit of Public Health, University of Alcalá, Alcalá de Henares, Madrid, Spain PubMed articlesGoogle scholar articles
  • Ildefonso Hernández-Aguado Center of Biomedical Network Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain Department of Public Health, Science, History and Gynaecology, Miguel Hernández University, Sant Joan d’Alacant, Spain PubMed articlesGoogle scholar articles
  • Nieves López Fresneña Department of Preventive Medicine and Public Health, Hospital Universitario Ramón y Cajal, Madrid, Spain Ramóny Cajal Biomedical Research Institute (IRYCIS), Madrid, Spain La Rioja International University (UNIR), Logroño, Spain PubMed articlesGoogle scholar articles
  • Cristina Díaz-Agero Pérez Department of Preventive Medicine and Public Health, Hospital Universitario Ramón y Cajal, Madrid, Spain Ramóny Cajal Biomedical Research Institute (IRYCIS), Madrid, Spain La Rioja International University (UNIR), Logroño, Spain PubMed articlesGoogle scholar articles
  • Enrique Terol García General Direction SANCO, Unit D2 Health Care Systems, Brussels, Belgium PubMed articlesGoogle scholar articles
  • Philippe Michel Centre Hospitalier Universitaire de Lyon, Université Claude Bernard Lyon 1, Lyon, France PubMed articlesGoogle scholar articles
  • Paulo Sousa Universidade Nova de Lisboa, Escola Nacional de Saude Publica. Centro deInvestigação em Saúde Pública-UNL, Lisboa, Portugal PubMed articlesGoogle scholar articles
  • Itziar Larizgoitia Jauregui Director General’s Office, World Health Organization, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • IBEAS Teamwork
    Google scholar articles
  1. Correspondence to Dr Nieves López Fresneña; nieves.lopez{at}salud.madrid.org
View Full Text

Citation

Aranaz Andrés JM, Limón Ramírez R, Aibar Remón C, et al
Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design
BMJ Open 2017;7:e016546. doi: 10.1136/bmjopen-2017-016546

Publication history

  • Received March 9, 2017
  • Revised September 14, 2017
  • Accepted September 15, 2017
  • First published October 8, 2017.
Online issue publication 
June 22, 2019
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/